CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer-Reference-Cited by-同舟云学术

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

Published:2006-06-25 Issue:7 Volume:38 Page:787-793
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Weisenberger Daniel J,Siegmund Kimberly D,Campan Mihaela,Young Joanne,Long Tiffany I,Faasse Mark A,Kang Gyeong Hoon,Widschwendter Martin,Weener Deborah,Buchanan Daniel,Koh Hoey,Simms Lisa,Barker Melissa,Leggett Barbara,Levine Joan,Kim Myungjin,French Amy J,Thibodeau Stephen N,Jass Jeremy,Haile Robert,Laird Peter W

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng1834.pdf

Reference24 articles.

1. Toyota, M. et al. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96, 8681–8686 (1999).

2. Issa, J.P. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4, 988–993 (2004).

3. Yamashita, K., Dai, T., Dai, Y., Yamamoto, F. & Perucho, M. Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 4, 121–131 (2003).

4. Anacleto, C. et al. Colorectal cancer “methylator phenotype”: fact or artifact? Neoplasia 7, 331–335 (2005).

5. Samowitz, W.S. et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129, 837–845 (2005).

Cited by 1660 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab;npj Precision Oncology;2024-09-14

2. BRAF-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities;Clinical Colorectal Cancer;2024-09

3. Colorectal Cancer with BRAF V600E Mutation: Trends in Immune Checkpoint Inhibitor Treatment;Critical Reviews in Oncology/Hematology;2024-09

4. The mechanisms and drug therapies of colorectal cancer and epigenetics: bibliometrics and visualized analysis;Frontiers in Pharmacology;2024-08-29

5. Concomitant expression patterns of CDX2 and SATB2 as prognostic factors in stage III colorectal cancers;Annals of Diagnostic Pathology;2024-08